Outset Medical, Inc. reaffirmed earnings guidance for the year 2024. The company reaffirmed its previously provided guidance for 2024 including revenue of $145 million to $153 million, growing 12% to 18% over 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | +3.93% | +20.64% | -16.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.82% | 233M | |
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.75% | 66.45B | |
+15.59% | 53.11B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Reaffirms Earnings Guidance for the Year 2024